Overview
Microfluidic in-vitro diagnostics and intelligent laboratory testing platform.
Funding
USD estimates from the source recordListed 1 funding record. Latest funding: $1.4M (战略投资), Nov 8, 2024.
Annual trendUnit: USD estimate
| Date | Amount | Investors | Source |
|---|---|---|---|
| Nov 8, 2024 | $1.4M | Kungaoxin Group |
Valuation
USD estimates from the source recordListed 1 valuation record.
Annual trendUnit: USD estimate
No chartable valuation estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Source |
|---|---|---|---|
| Nov 8, 2024 | — | Kungaoxin Group |
Revenue
USD estimates from the source recordNo revenue records are listed yet.
Annual trendUnit: USD estimate
No chartable revenue estimates yet.
No revenue rows to list.
Team, products & investors
Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
微流控体外诊断与智慧检验平台